These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15531941)

  • 1. [Biochemical markers of cardiac injury and strain in the risk stratification of patients with acute pulmonary embolism].
    Kostrubiec M; Bochowicz A; Pruszczyk P
    Kardiol Pol; 2004 Sep; 61(9):277-81. PubMed ID: 15531941
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism.
    Kucher N; Goldhaber SZ
    Circulation; 2003 Nov; 108(18):2191-4. PubMed ID: 14597581
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms.
    Punukollu G; Khan IA; Gowda RM; Lakhanpal G; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2005 Mar; 99(2):207-11. PubMed ID: 15749177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of acute pulmonary embolism.
    Kucher N; Goldhaber SZ
    Semin Thromb Hemost; 2006 Nov; 32(8):838-47. PubMed ID: 17171598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality from pulmonary embolism and their influence on clinical management.
    Becattini C; Agnelli G
    Thromb Haemost; 2008 Nov; 100(5):747-51. PubMed ID: 18989514
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiac biomarkers and pulmonary embolism: prognostic stratification].
    Blaudszun G; Vuilleumier N; Righini M; Louis-Simonet M
    Rev Med Suisse; 2009 Oct; 5(221):2022-4, 2026-7. PubMed ID: 19911687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide as an indicator of right ventricular dysfunction in acute pulmonary embolism.
    Yardan T; Altintop L; Baydin A; Yilmaz O; Guven H
    Int J Clin Pract; 2008 Aug; 62(8):1177-82. PubMed ID: 17537186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins.
    Becattini C; Vedovati MC; Agnelli G
    Expert Rev Mol Diagn; 2008 May; 8(3):339-49. PubMed ID: 18598112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism.
    Pieralli F; Olivotto I; Vanni S; Conti A; Camaiti A; Targioni G; Grifoni S; Berni G
    Am J Cardiol; 2006 May; 97(9):1386-90. PubMed ID: 16635617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic score and short-term outcomes of acute pulmonary embolism.
    Toosi MS; Merlino JD; Leeper KV
    Am J Cardiol; 2007 Oct; 100(7):1172-6. PubMed ID: 17884383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis for hemodynamically stable patients with pulmonary embolism: still searching for the intermediate-risk group.
    Lankeit M; Konstantinides S
    Thromb Res; 2009 Dec; 124(6):647-8. PubMed ID: 19664803
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism.
    Kaczyñska A; Pelsers MM; Bochowicz A; Kostrubiec M; Glatz JF; Pruszczyk P
    Clin Chim Acta; 2006 Sep; 371(1-2):117-23. PubMed ID: 16698008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide in acute pulmonary embolism.
    Kaczyńska A; Kostrubiec M; Ciurzyński M; Pruszczyk P
    Clin Chim Acta; 2008 Dec; 398(1-2):1-4. PubMed ID: 18706401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can elevated troponin I levels predict complicated clinical course and inhospital mortality in patients with acute pulmonary embolism?
    Aksay E; Yanturali S; Kiyan S
    Am J Emerg Med; 2007 Feb; 25(2):138-43. PubMed ID: 17276801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it possible to use standard electrocardiography for risk assessment of patients with pulmonary embolism?
    Kostrubiec M; Hrynkiewicz A; Pedowska-Włoszek J; Pacho S; Ciurzyński M; Jankowski K; Koczaj-Bremer M; Wojciechowski A; Pruszczyk P
    Kardiol Pol; 2009 Jul; 67(7):744-50. PubMed ID: 19649996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-B-type natriuretic peptide as a marker of pulmonary embolism in pregnancy: a case report.
    Franz MB; Guenthner-Biller MM; Kainer F; Schiessl B
    Arch Gynecol Obstet; 2008 May; 277(5):439-40. PubMed ID: 18293006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognosis of pulmonary embolism: are there practical implications for patient management?].
    Aujesky D; Mazzolai L; Perrier A
    Rev Med Suisse; 2006 Jan; 2(50):281-4. PubMed ID: 16503044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary embolism risk stratification: the intermediate-risk group.
    Paiva L; Barra S; Providência R
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):896-8. PubMed ID: 24176951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrocardiography for risk assessment of patients with pulmonary embolism].
    Bryniarski L
    Kardiol Pol; 2009 Jul; 67(7):751-2. PubMed ID: 19750608
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac biomarkers in pulmonary embolism.
    Lippi G; Favaloro EJ
    Thromb Haemost; 2008 Jun; 99(6):1134-6. PubMed ID: 18521526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.